iScience sees $20.5M for eye surgery instruments
iScience Interventional, maker of surgical tools for eye operations, has closed a prolonged sixth round of funding at $20.5 million after facing a bit more of a challenge due to the economic climate. The money will be used to commercialize its line of micro-catheters used to remove fluid from or deliver medication to the back region of people’s eyes. It hopes to have them on the market by the end of 2010 at the latest,… Continue Reading
Life sciences briefing: Tuesday, Jan. 29, 2008
TODAY’S HEADLINES:
Immune-system specialty pharma Circassia raises £11M (release)
Cancer-biomarker biotech CS-Keys takes in $6.3M (release)
Neuro-robotic device maker Myomo receives $3M (VentureWire)
Micropharma draws C$1.8M for nutraceutical delivery (VentureWire)
Avalon Labs gets $66M for disposable life-support components (release)
Gloucester Pharma names Alan Colowick as CEO (release)
ConforMIS names Philipp Lang as CEO (release)
Pharma-marketing firm TargetRx names Craig Scott as CEO (release)
Immune-system specialty pharma Circassia raises £11M – Circassia, an Oxford, England biotech focused on immune-system disorders, raised £11 million ($21.8 million) in… Continue Reading